Cite
HARVARD Citation
Adebajo, A. et al. (2014). SAT0377 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial. Annals of the rheumatic diseases. p. 730. [Online].